Innexus Biotechnology Inc

(IXSBF)

By |

Profile

InNexus Biotechnology Inc is engaged in commercializing the next generation of monoclonal antibodies based on its DXL technology, which improves the potency of existing antibody products while opening new markets and disease applications.

Contact Information

Website: www.ixsbio.com
Email: ipr@ixsbio.com
Main Phone: +1 480 862-7500
Address: 1500 Royal Centre
Address 2: 1055 West Georgia Street
State: BC
City / Town: Vancouver
Country: CAN
Postal Code: V6E 4N7

Issuer Information

Exchange: CVEM
NAICS: Pharmaceutical P
$ 0.0001 $ 0. (0.00%)
Last Price 0.0001 Change $ 0. Change % 0.00 Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close 0.0001
Last Trade Volume 0 52 Wk Hi 0.0015 52 Wk Low 0.
Market Cap 12,627 Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 126,270,651.00 EPS (TTM) -0.04 PE Ratio N/A Exchange CV EM